353 related articles for article (PubMed ID: 15569526)
1. [Preparation of rAAV2/hFIX and experimentally application to gene therapy for hemophilia B].
Peng JQ; Dong XY; Peng M; Chen L; Tan SP; Yuan H; Chen FP; Xue JL; Wu XB
Zhonghua Xue Ye Xue Za Zhi; 2004 Sep; 25(9):513-8. PubMed ID: 15569526
[TBL] [Abstract][Full Text] [Related]
2. Persistent expression of canine factor IX in hemophilia B canines.
Chao H; Samulski R; Bellinger D; Monahan P; Nichols T; Walsh C
Gene Ther; 1999 Oct; 6(10):1695-704. PubMed ID: 10516718
[TBL] [Abstract][Full Text] [Related]
3. Sustained and therapeutic levels of human factor IX in hemophilia B mice implanted with microcapsules: key role of encapsulated cells.
Wen J; Vargas AG; Ofosu FA; Hortelano G
J Gene Med; 2006 Mar; 8(3):362-9. PubMed ID: 16311997
[TBL] [Abstract][Full Text] [Related]
4. Implantation of autologous skin fibroblast genetically modified to secrete clotting factor IX partially corrects the hemorrhagic tendencies in two hemophilia B patients.
Qiu X; Lu D; Zhou J; Wang J; Yang J; Meng P; Hsueh JL
Chin Med J (Engl); 1996 Nov; 109(11):832-9. PubMed ID: 9275366
[TBL] [Abstract][Full Text] [Related]
5. Theodore E. Woodward Award. AAV-mediated gene transfer for hemophilia.
High KA
Trans Am Clin Climatol Assoc; 2003; 114():337-51; discussion 351-2. PubMed ID: 12813929
[TBL] [Abstract][Full Text] [Related]
6. Encapsulated human primary myoblasts deliver functional hFIX in hemophilic mice.
Wen J; Xu N; Li A; Bourgeois J; Ofosu FA; Hortelano G
J Gene Med; 2007 Nov; 9(11):1002-10. PubMed ID: 17868187
[TBL] [Abstract][Full Text] [Related]
7. Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors.
Snyder RO; Miao CH; Patijn GA; Spratt SK; Danos O; Nagy D; Gown AM; Winther B; Meuse L; Cohen LK; Thompson AR; Kay MA
Nat Genet; 1997 Jul; 16(3):270-6. PubMed ID: 9207793
[TBL] [Abstract][Full Text] [Related]
8. [Expression of coagulation factor IX in human CD34 + hematopoietic stem cells by adeno-associated virus 2].
Chen Y; Chen FP; Peng JQ; Wu XB; Wang GP; Jian ZF; Xin HY; Wu XH
Zhonghua Xue Ye Xue Za Zhi; 2005 Sep; 26(9):529-33. PubMed ID: 16468329
[TBL] [Abstract][Full Text] [Related]
9. Gene therapy for hemophilia.
Lynch CM
Curr Opin Mol Ther; 1999 Aug; 1(4):493-9. PubMed ID: 11713765
[TBL] [Abstract][Full Text] [Related]
10. Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectors.
Snyder RO; Miao C; Meuse L; Tubb J; Donahue BA; Lin HF; Stafford DW; Patel S; Thompson AR; Nichols T; Read MS; Bellinger DA; Brinkhous KM; Kay MA
Nat Med; 1999 Jan; 5(1):64-70. PubMed ID: 9883841
[TBL] [Abstract][Full Text] [Related]
11. A comparative study of hFIX expression mediated by rAAV8 and rAAV1 administrated intramuscularly.
Cao Z; Zheng P; Lin Y
Cytotherapy; 2007; 9(6):593-9. PubMed ID: 17882724
[TBL] [Abstract][Full Text] [Related]
12. Hepatic control elements promote long-term expression of human coagulation factor IX gene in hydrodynamically transfected mice.
Kim HS; Kim JC; Lee YK; Kim JS; Park YS
J Gene Med; 2011 Jul; 13(7-8):365-72. PubMed ID: 21710610
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus vectors provide prolonged robust factor IX expression in mice.
Sclimenti CR; Neviaser AS; Baba EJ; Meuse L; Kay MA; Calos MP
Biotechnol Prog; 2003; 19(1):144-51. PubMed ID: 12573017
[TBL] [Abstract][Full Text] [Related]
14. FIX-Triple, a gain-of-function factor IX variant, improves haemostasis in mouse models without increased risk of thrombosis.
Kao CY; Lin CN; Yu IS; Tao MH; Wu HL; Shi GY; Yang YL; Kao JT; Lin SW
Thromb Haemost; 2010 Aug; 104(2):355-65. PubMed ID: 20539913
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow stromal cells as a genetic platform for systemic delivery of therapeutic proteins in vivo: human factor IX model.
Krebsbach PH; Zhang K; Malik AK; Kurachi K
J Gene Med; 2003 Jan; 5(1):11-7. PubMed ID: 12516047
[TBL] [Abstract][Full Text] [Related]
16. [Development of rAAV2-GAD-Ig for IDDM gene therapy].
Wang RX; Wang JA; Song L; Han GC; Shen BF; Wu XB; Li Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Jan; 21(1):24-8. PubMed ID: 15629077
[TBL] [Abstract][Full Text] [Related]
17. [Exploration of high expressions of retroviral vectors containing hFIX minigene in murine myoblast cells].
Hou J; Wang J; Min B
Zhonghua Xue Ye Xue Za Zhi; 2001 Mar; 22(3):121-4. PubMed ID: 11877060
[TBL] [Abstract][Full Text] [Related]
18. Gene therapy for hemophilia B mice with scAAV8-LP1-hFIX.
Lu W; Zhou Q; Yang H; Wang H; Gu Y; Shen Q; Xue J; Dong X; Chen J
Front Med; 2016 Jun; 10(2):212-8. PubMed ID: 27052253
[TBL] [Abstract][Full Text] [Related]
19. [Quality control of recombinant adeno-associated virus type 2/human blood coagulation factor IX].
Gao K; Wang JZ; Rao CM; Wu XB
Yao Xue Xue Bao; 2003 Sep; 38(9):684-9. PubMed ID: 14730919
[TBL] [Abstract][Full Text] [Related]
20. [Construction and expression of recombinant adeno-associated virus vector containing HSV1-TK gene].
Ding ZX; Tan Q; Liu SZ; Liu D; Li ZQ; Peng JQ
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Mar; 33(3):210-5. PubMed ID: 18382054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
